Page 47 - தகவல்கள் பாதுகாப்பு கண்காணிப்பு பலகை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cambridge, MA  biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, Moderna, Inc., announced Friday that the U.S. Food and Drug Administration’s (FDA) has authorized the emergency use of mRNA-1273, Moderna’s vaccine against COVID-19 in individuals 18 years of age or older. Image/Moderna Twitter The Moderna COVID-19 Vaccine is now authorized for distribution and use under an Emergency Use Authorization (EUA). Delivery to the U.S. Government will begin immediately. Moderna will continue to gather additional data and plans to file a Biologics License Application (BLA) with the FDA requesting full licensure in 2021. “I want to thank the thousands of participants in our clinical trials and the staff at our clinical trial sites who have been on the front lines of the fight against the virus. I want to thank the NIH and NIAID for their scientific leadership and our partners at BARDA and Operation Warp Speed who have been instrumental to accelera

United statesUnited kingdomUs centers for diseaseDepartment of defenseHuman servicesNational institutes of healthDrug administrationAdvisory committee on immunization practicesDepartment of healthModerna incEmergency use authorizationBiologics license applicationOperation warp speedChief executive officerDisease controlAdvisory committee